Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/09/1999US5981601 Method for enhancing cellular bioenergy
11/09/1999US5981599 Inorganic ion receptor active compounds
11/09/1999US5981598 Administering a therapeutically effective amount of a deprenyl compound to a subject such that the subject is treated for glaucoma
11/09/1999US5981597 Differentiating agents for the treatment of inflammatory intestinal diseases
11/09/1999US5981594 Method of treatment for diabetic neuropathy
11/09/1999US5981593 Prostaglandin E2 treatment of impotence
11/09/1999US5981592 Administering to a patient in need of said treatment a composition comprising an effective therapeutic amount of an enantiomerically stable r-nsaid or pharmaceutically acceptable salt thereof, said composition being free of s-enantiomer
11/09/1999US5981591 Sprayable analgesic composition and method of use
11/09/1999US5981590 Orally administering glutamine
11/09/1999US5981589 Copolymer-1 improvements in compositions of copolymers
11/09/1999US5981588 Administering to a patient an omega 9-unsaturated fatty acid having at least two double bonds in an amount effective for preventing or alleviating medical symptoms caused by delayed allergy reaction
11/09/1999US5981587 Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
11/09/1999US5981586 Methods for treating proliferative and inflammatory skin diseases
11/09/1999US5981583 For use in the treatment of pathological conditions such as toxic shock, acute inflammatory conditions, acute phase response, atherosclerosis and cancer
11/09/1999US5981582 Compositions and methods of combatting fungi
11/09/1999US5981579 Use of nitrovasodilators for treatment of disease or stress conditions in a non-human mammal
11/09/1999US5981578 Increased solubilization and stable cosmetic preparations of ascorbic acid
11/09/1999US5981575 Inhibition of fatty acid synthase as a means to reduce adipocyte mass
11/09/1999US5981574 Phenanthrofuran derivatives
11/09/1999US5981572 Treatment of disorders which arise from a disturbed functioning of systems which are regulated by melatonin; in particular in the treatment of chronobiological disorders, especially in the elderly
11/09/1999US5981571 Benzodioxa alkylene ethers as melatonergic agents
11/09/1999US5981570 Benzothiophene compounds, compositions, and methods
11/09/1999US5981569 Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
11/09/1999US5981568 Therapeutic inhibitor of vascular smooth muscle cells
11/09/1999US5981563 Orally administering a rapidly dissolving tablet comprising phentolamine or its pharmaceutically acceptable salts
11/09/1999US5981562 Inhibitors of farnesyl-protein transferase
11/09/1999US5981560 1,2,4-triazole fungicides
11/09/1999US5981559 Azole derivative with leukotriene (LTs) antagonizing activity and thromboxane (TX) A2 antagonizing activity
11/09/1999US5981556 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
11/09/1999US5981555 Administration of hypolipemic amounts of niacin and nonsteroidal antiinflammatory drug; having reduced capacity to provoke a flushing reaction in a subject
11/09/1999US5981553 Heterocycle substituted propenoic acid derivatives as NMDA antagonist
11/09/1999US5981552 Sublingual and buccal compositions of droperidol and method for treating migraine
11/09/1999US5981551 2,5-diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroimidazo[4,5-d]imidazoles which are effective as G-CSF mimetics
11/09/1999US5981549 For controlling respiratory disease or allergies or alleviating symptoms of such diseases; non-aryl oxime derivative
11/09/1999US5981547 Homochroman derivatives and related compounds useful as anti-inflammatory agents
11/09/1999US5981546 Integrin antagonists
11/09/1999US5981545 N-linked azabicyclic heterocycles useful for treating dementia
11/09/1999US5981544 For treatment of diseases involving an alteration in the venous function and/or inflammatory edema
11/09/1999US5981543 Method of treating androgenic alopecia with 5α-reductase inhibitors
11/09/1999US5981541 Substituted heterocycles as anti-tumor agents
11/09/1999US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999US5981539 Piperidine compounds as calcium channel blockers
11/09/1999US5981538 Skin disorders
11/09/1999US5981537 Pyrimidine-thioalkyl and alkylether compounds
11/09/1999US5981536 Use of xanthine derivatives for the modulation of apoptosis
11/09/1999US5981535 Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases
11/09/1999US5981533 Pyrazole derivatives and processes for the preparation thereof
11/09/1999US5981531 For inhibiting platelet aggregation
11/09/1999US5981529 Substituted indolylpropyl-piperazine derivatives as 5-HT1D α agonists
11/09/1999US5981528 Treating a bacterial infection
11/09/1999US5981527 Cyclic GMP-specific phosphodiesterase inhibitors
11/09/1999US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999US5981524 Substituted 9-alkyladenines
11/09/1999US5981522 Administering rifamycin derivative to the patient to treat gastritis, gastroduodenitis, erosive gastritis, gastric erosion, erosive duodenitis, gastric ulcer and duodenal ulcer caused by helicobacter plori
11/09/1999US5981521 Tetrahydroisoquinoline derivatives as LHRH antagonists
11/09/1999US5981519 Useful for treatment and prophylaxis of infectious diseases, especially those caused by methicillin resistant staphylococcus aureus and pseudomonas aeruginosa
11/09/1999US5981518 Gallium complexes of 3-hydroxy-4-pyrones to treat or prevent calcium homeostasis disorders
11/09/1999US5981517 Androstene derivatives
11/09/1999US5981516 Treating cholesterol without estrogenic activity at the uterine level in women comprising administering to women an amount of a steroid
11/09/1999US5981513 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/09/1999US5981512 Means for treating radiation injuries
11/09/1999US5981511 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
11/09/1999US5981510 Administering compounds selected from chitin oligosaccharides, chitosan oligosaccharide and their salts to treat non-insulin dependent diabetic patients
11/09/1999US5981509 Preparation for prophylaxis or treatment of renal diseases containing sulfated polysaccharide
11/09/1999US5981508 Facilitation of repair of neural injury with CM101/GBS toxin
11/09/1999US5981506 Method for treating sinusitis with uridine triphosphates and related compounds
11/09/1999US5981499 Topically administering in dry form a troche or a powder consisting of a dry dosage of an antibiotic selected from penicillins, beta-lactam antibiotics, tetracyclines, aminoglycosides, cephalosporins, macrolides, vancomycin salts
11/09/1999US5981498 Agent for improving the blood circulation
11/09/1999US5981497 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
11/09/1999US5981496 Hydroxypryrone derivatives or hydroxythiopyrone derivatives used to treat bacterial or cancer cell expansion
11/09/1999US5981495 Benzopyran derivative and method for treating heart disease using this derivative
11/09/1999US5981494 Administering to the mammal a glycosidase inhibitor to inhibit the conversion of pro-toxin to toxin which causes maleria, endotoxic shock or septic shock in mammals
11/09/1999US5981492 Substituted 5-membered ring heterocycles, their preparation and their use
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981487 Method of inhibiting smooth muscle cell proliferation
11/09/1999US5981472 Methods for treating diseases
11/09/1999US5981470 Administering pharmaceutical agent selected from the group consisting of an angiotensin converting enzyme inhibitor, an angiotensin ii-receptor antagonist, a renin inhibitor, and an angiotensin ii-receptor expression inhibitor
11/09/1999US5981252 Enzyme for diagnosis of atherosclerosis; for screening enzyme inhibitors as therapy
11/09/1999US5981246 Nucleic acids encoding EPH-like receptor protein tyrosine kinases
11/09/1999US5981245 Polypeptide kinase coded by a nucleic acid sequence; antibody development; for modulating kinase receptor activation and detecting receptor ligands
11/09/1999US5981168 Method and composition for modulating amyloidosis
11/09/1999US5981132 Non-magnetic mono-component developer
11/09/1999US5980952 Comprising rapid-release minigranules and slow-release minigranules; for delivering two concentration peaks of dexfenfluramine in the plasma to treat obesity
11/09/1999US5980951 Oral coated active drugs
11/09/1999US5980950 Thrombolytic agents and methods of treatment for thrombosis
11/09/1999US5980949 Formulation for inhalation
11/09/1999US5980946 Collagen formulations
11/09/1999US5980944 Simethicone containing pharmaceutical compositions
11/09/1999US5980943 A time release dosage form comprising a semipermeable wall in contact with a therapeutic drug granules coated with polyoxyalkylene glycol
11/09/1999US5980941 A glycerine-free tabletable mixture comprising a saccharide carrier and the sugar alcohols sorbitol and xylitol; forming tablets
11/09/1999US5980940 Pharmaceutical combination preparation for hormonal contraception
11/09/1999US5980938 Administering a dibenzyl benzopyrans
11/09/1999US5980933 Transdermal formulation of xanomeline
11/09/1999US5980932 Solid matrix system for transdermal drug delivery
11/09/1999US5980929 Prophylactic and therapeutic treatment of eye disorders
11/09/1999US5980925 A washing solution comprising an anchoring agent for improving the efficacy of a polar microbiocide agent on the skin; hand washes, wound cleansers, body washes, mouthwashes, surgical scrubs
11/09/1999US5980918 A wound and burns healing mixture in creams and gels
11/09/1999US5980915 Administering an antiprotozoa agent
11/09/1999US5980914 Administering an amount of clioquinol with vitamin b12 effective to treat or delay the onset of parkinson's disease
11/09/1999US5980905 Supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass; in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb
1 ... 6416 6417 6418 6419 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 ... 7860